Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray

European Journal of Human Genetics

Volumn 25, Issue 12, 2017, Pages 1303-1312

  Hayeems, Robin Z ^a,b   Bhawra, Jasmin ^c   Tsiplova, Kate ^a   Meyn, M Stephen ^a,d   Monfared, Nasim ^a   Bowdin, Sarah ^a,d   Stavropoulos, D James ^a,e   Marshall, Christian R ^a,e,f   Basran, Raveen ^a   Shuman, Cheryl ^a,d   Ito, Shinya ^a   Cohn, Iris ^a   Hum, Courtney ^g   Girdea, Marta ^a   Brudno, Michael ^a,d   Cohn, Ronald D ^a,d   Scherer, Stephen W ^a,d,f   Ungar, Wendy J ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF WATERLOO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; CHROMOSOME; CONTROLLED STUDY; DEVELOPMENTAL DELAY; FEMALE; GENETIC SCREENING; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PEDIATRICS; PRIORITY JOURNAL; WHOLE GENOME SEQUENCING; CANADA; COMPARATIVE STUDY; COST; DNA MICROARRAY; ECONOMICS; PROCEDURES;

CANADA; CHILD; COSTS AND COST ANALYSIS; GENETIC TESTING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; WHOLE GENOME SEQUENCING;

EID: 85034601478     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/s41431-017-0020-3     Document Type: Article

References (43)

1. Wade C, Tarini BA, Wilfond BS. Growing up in the genomic era: implications of whole-genome sequencing for children, families, and pediatric practice. Annu Rev Genom Hum Genet 2013;14:535-55.
2. Manolio TA, Chisholm RL, Ozenberger B, et al. Implementing genomic medicine in the clinic: the future is here. Genet Med 2013;15:258-67.
3. Johansen Taber KA, Dickinson BD, Wilson M. The promise and challenges of next-generation genome sequencing for clinical care. JAMA Intern Med 2014;174:275-80.
4. Next steps in the sequence: the implications of whole genome sequencing for health in the UK. October 2011 © 2011 PHG Foundation. http://www. phgfoundation. org/file/10363. Accessed 10 November 2016.
5. van Nimwegen K, Schieving J, Willemsen M, et al. The diagnostic pathway in complex paediatric neurology: a cost analysis. Eur J Paediat Neurol 2015;19:233-39.
6. Richards J, Korgenski EK, Srivastava R, Bonkowsky JL. Costs of the diagnostic odyssey in children with inherited leukodystrophies. Neurology 2015;85:1167-70.
7. Stavropoulos DJ, Merico D, Jobling R, et al. Whole genome sequencing expands diagnostic utility and improves clinical management in pediatric medicine. NPJ Genom Med. 1 pii:15012 Epub: 2016.
8. Gilissen C, Hehir-Kwa JY, Thung DT, et al. Genome sequencing identifies major causes of severe intellectual disability. Nature 2014;511:344-7.
9. Soden SE, Saunders CJ, Willig LK, et al. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci Transl Med 2014;6:265ra168.
10. Vozikis A, Cooper DN, Mitropoulou C, et al. Test pricing and reimbursement in genomic medicine: towards a general strategy. Public Health Genom 2016;19:352-63. [Epub ahead of print]
11. National Institute for Health and Clinical Excellence. Diagnostics Assessment Programme manual December 2011. https://www. nice. org. uk/Media/Default/About/what-we-do/NICE-guidance/ NICE-diagnostics-guidance/Diagnostics-assessment-programmemanual. pdf
12. Ferrante di Ruffano L, Hyde CJ, McCaffery KJ, Bossuyt PM, Deeks JJ. Assessing the value of diagnostic tests: a framework for designing and evaluating trials. BMJ 2012;344:e686.
13. Bossuyt PM, Reitsma JB, Linnet K, Moons KG. Beyond diagnostic accuracy: the clinical utility of diagnostic tests. Clin Chem 2012;58:1636-43.
14. Caulfield T, Evans J, McGuire A, et al. Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate. PLoS Biol 2013;11:e1001699.
15. ACMG Board of Directors. Clinical utility of genetic and genomic services: a position statement of the American College of medical genetics and genomics. Genet Med 2015;17:505-7.
16. Bainbridge MN, Wiszniewski W, Murdock DR, et al. Wholegenome sequencing for optimized patient management. Sci Transl Med 2011;3:87re3.
17. Link DC, Schuettpelz LG, Shen D, et al. Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML. JAMA 2011;305:1568-76.
18. Saunders CJ, Miller NA, Soden SE, et al. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci Transl Med 2012;4:154ra135.
19. Worthey EA, Mayer AN, Syverson GD, et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med 2011;13:255-62.
20. Iglesias A, Anyane-Yeboa K, Wynn J, et al. The usefulness of whole-exome sequencing in routine clinical practice. Genet Med 2014;16:922-31.
21. Tan TY, Dillon OJ, Stark Z, et al. Diagnostic impact and costeffectiveness of whole-exome sequencing for ambulant children with suspected monogenic conditions. JAMA Pediatr. Published online 31 July 2017. https://doi. org/10. 1001/jamapediatrics. 2017. 1755
22. Henderson LB, Applegate CD, Wohler E, Sheridan MB, Hoover-Fong J, Batista DA. The impact of chromosomal microarray on clinical management: a retrospective analysis. Genet Med 2014;16:657-64.
23. Coulter ME, Miller DT, Harris DJ, et al. Chromosomal microarray testing influences medical management. Genet Med 2011;13:770-776.
24. Saam J, Gudgeon J, Aston E, Brothman AR. How physicians use array comparative genomic hybridization results to guide patient management in children with developmental delay. Genet Med 2008;10:181-6.
25. Hayeems RZ, Hoang N, Chenier S, et al. Capturing the clinical utility of genomic testing: medical management following pediatric microarray. Eur J Hum Gen 2015;23:1135-41.
26. Vassy JL, Lautenbach DM, McLaughlin HM, et al The MedSeq project: a randomized trial of integrating whole genome sequencing into clinical medicine. Trials. 2014;15:85.
27. Bowdin SC, Hayeems RZ, Monfared N, Cohn RD, Meyn MS. The SickKids genome clinic: developing and evaluating a pediatric model for individualized genomic medicine. Clin Genet 2016;89:10-9
28. Bowdin S, Ray PN, Cohn RD, Meyn MS. The genome clinic: a multidisciplinary approach to assessing the opportunities and challenges of integrating genomic analysis into clinical care. Hum Mutat 2014;35:513-9.
29. Kearney HM, Thorland EC, Brown KK, Quintero-Rivera F, South ST. Working group of the American College of Medical Genetics Laboratory Quality Assurance C et al. American college of medical genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med 2011;13:680-5.
30. Drmanac R, Sparks AB, Callow MJ, et al. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science 2010;327:78-81.
31. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010;38:e164.
32. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadatadriven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377-81.
33. Girdea M, Dumitriu S, Fiume M, et al. PhenoTips: patient phenotyping software for clinical and research use. Hum Mutat 2013;34:1057-65.
34. Robinson PN, Köhler S, Bauer S, et al. The human phenotype ontology: a tool for annotating and analyzing human hereditary disease. Am J Hum Genet 2008;83:610-15.
35. Ontario Ministry of Health and Long-Term Care. 1999. OHIP Schedule of Benefits and Fees, Schedule of Benefits for Laboratory Services. http://www. health. gov. on. ca/en/pro/programs/ohip/ sob/lab/lab-services-sched-01-19990401. pdf
36. Ontario Ministry of Health and Long-Term Care. 2016. OHIP Schedule of Benefits and Fees, Physician Services under the Health Insurance Act. http://www. health. gov. on. ca/en/pro/progra ms/ohip/sob/physserv/sob-master20160401. pdf.
37. R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2016. ISBN 3-900051-07-0
38. Christensen KD, Dukhovny D, Siebert U, Green RC. Assessing the costs and cost-effectiveness of genomic sequencing. J Pers Med 2015;5:470-86.
39. Tsiplova K, Zur RM, Marshall CR, Stavropoulos DJ, Pereira SL, Merico D, Young EJ, Sung WWL, Scherer SW, Ungar WJ. A microcosting and cost-consequence analysis of clinical genomic testing strategies in autism spectrum disorder. Genet Med. 2017 May 4. https://doi. org/10. 1038/gim. 2017. 47. [Epub ahead of print].
40. Cohen E, Berry JG, Camacho X, Anderson G, Wodchis W, Guttmann A. Patterns and costs of health care use of children with medical complexity. Pediatrics 2012;130:e1463.
41. Cohn I, Paton TA, Marshall CR, Basran R, Stavropoulos DJ, Ray PN, Monfared N et al. Genome sequencing as a platform for pharmacogenetic information: a cohort study. npj Genomic Medicine 2017;2:1.
42. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L. The continuum of translation research in genomic medicine: How can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 2007;9:665-74.
43. Steuten LMG. Early stage health technology assessment for precision biomarkers in oral health and systems medicine. OMICS: J Integ Biol 2016;20:30-35.